🔎 Trials Near Me

Akèy › Emofili B › Michigan

Etid klinik pou Emofili B nan Michigan

6 etid pou Emofili B ap chèche patisipan nan sit nan Michigan.

Vil nan Michigan

Tèks ofisyèl etid la (Anglè)

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

  • University of Michigan Medical Center, Ann Arbor
Ap rekriteFaz 3
138 Months – 206 Months · Gason · Mizajou Sep 16, 2026 · NCT07080905

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Central Michigan Children's Hospital of Michigan, Detroit
  • Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Jul 2, 2026 · NCT06349473

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

  • Children's Hospital of Michigan, Detroit
  • Henry Ford Health System, Detroit
  • MSU Center for Bleeding and Clotting Disorders, Lansing
Ap rekriteFaz 4
Laj 12 a 100 · Tout sèks · Mizajou Jan 12, 2026 · NCT04647227

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.